ITeos Therapeutics Stock (NASDAQ: ITOS) stock price, news, charts, stock research, profile.
Open | $17.940 |
Close | - |
Volume / Avg. | 157.805K / 403.953K |
Day Range | 17.500 - 18.425 |
52 Wk Range | 8.200 - 18.750 |
Market Cap | $662.314M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 80 |
Short Interest | 10.85% |
Days to Cover | 8.21 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ITeos Therapeutics (NASDAQ: ITOS) through any online brokerage.
Other companies in ITeos Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Altimmune (NASDAQ:ALT) and Sage Therapeutics (NASDAQ:SAGE).
The latest price target for ITeos Therapeutics (NASDAQ: ITOS) was reported by HC Wainwright & Co. on Monday, May 13, 2024. The analyst firm set a price target for 46.00 expecting ITOS to rise to within 12 months (a possible 150.89% upside). 6 analyst firms have reported ratings in the last year.
The stock price for ITeos Therapeutics (NASDAQ: ITOS) is $18.335 last updated Today at May 16, 2024 at 1:20 PM EDT.
There are no upcoming dividends for ITeos Therapeutics.
ITeos Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for ITeos Therapeutics.
ITeos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.